REFERENCES

  1. World Health Organization. Human papillomavirus (HPV) and cervical cancer. 2020. Available at https://www.who.int/news-room/fact-sheets/detail/cervical-cancer Accessed 4 January 2023.
  2. World Health Organization. HPV LabNet Newsletter. 2011;8:1-13.
  3. Chesson HW, Dunne EF, Hariri S, et. al. The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States. Sex Transm Dis. 2014;41(11):660-664. (In addition to: Data available on request from Merck Professional Services-OAP, WP1-27, PO Box).
  4. de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide cancer burden attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141:664-670.
  5. World Health Organization. Latest World cancer statistics Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancer must be addressed. 2013. Available at: https://www.iarc.fr/wp-content/uploads/2018/07/pr223_E.pdf. Published: December 12, 2013. Accessed 28 November 2021.
  6. Senkomago V, Henley SJ, Thomas CC, et al. Human papillomavirus-attribute cancers – United States, 2012-2016. MMWR. Morbidity and Mortality Weekly Report 2019;68(33):724-728.
  7. The American College of Obstetricians and Gynecologists. Human Papillomavirus Frequently Asked Questions For Providers. Available at: https://www.acog.org/programs/immunization-for-women/physician-tools/human-papillomavirus-frequently-asked-questions-for-providers Accessed 5 January 2023.
  8. Patel H, Wagner M, Singhal P, et al. Systematic review of the incidence and prevalance of genital warts. BMC Infect Dis. 2013;13:39. Available at: http://www.biomedcentral.com/1471-2334/13/39. Accessed 28 November 2021.
  9. United States Census Bureau. International database worldwide population by age and sex. Available at: https://www.census.gov/programs-surveys/international-programs/about/idb.html. Accessed 4 January 2023.
  10. World Health Organization (WHO). WHO guidelines for treatment of cervical intraepithelial neoplasia 2-3 and adenocarcinoma in situ: cryotherapy, large loop excision of the transformation zone, and cold knife conization. 2014. Available at: http://apps.who.int/iris/bitstream/10665/104174/1/9789241506779_eng.pdf. Accessed 28 November 2021.
  11. Guan P, Howell-Jones R, Li N, et al. Human papillomavirus types in 115,780 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349-2359.
  12. Alemany L, Saunier M, Tinoco L, et al. Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer. 2014;50(16):2846-2854.
  13. Hartwig S, et al. Estimation of the epidermiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in woman and men in Europe: Potential additional benefit of a nin-valent second generation HPV vaccine compared to first generation HPV vaccines. Papillomavirus Research. 2015;1:90-100.
  14. Alemany L, Saunier M, Alvarado-Cabrero I, et al. Human papillomavirus DNA prevalance and type distribution in anal carcinomas worldwide. Int J cancer. 2015;136(1):98-107. HQ
  15. de Sanjose S, Alemany L, Ordi J, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49(16):3450-3461.
  16. Centers for Disease Control and Prevention (CDC). STD Facts - Human papillomavirus (HPV). 2021. Available at: https://www.cdc.gov/std/hpv/stdfact-hpv.htm Accessed 28 November 2021.
  17. Centers for Disease Control and Prevention (CDC). Human papillomavirus. In: Hamborsky J, Kroger A, Wolfe C, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington DC: Public Health Foundation; 2015:175-186.
  18. Campbell CM, Lin Y, Fulp W, et al. Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study. J Infect Dis. 2013;208:373-384.
  19. Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: Recommendations of Advisory Committee on Immunication Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63(5):1-30.
  20. Centers for Disease Control and Prevention (CDC). The link between HPV and Cancer. Available at: https://www.cdc.gov/hpv/parents/cancer.html. 28 November 2021.
  21. Yanofsky VP, Patel RV, Goldenberg G. Genital warts: a comprehensive review. J Clin Aesthet Dermatol. 2012;5(6):25-36.
  22. Dempsey A. Human Papillomavirus: The Usefulness of Risk Factors in Determining Who Should Get Vaccinated. Rev Obstet Gnecol. 2008;1(3):122-128. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC258644/pdf/RIOG001003_0122.pdf Accessed 13th January 2022.
  23. Centers for Disease Control and Prevention (CDC). Vaccination Coverage among Adults in the United States, National Health Interview Survey, 2017. Available at: https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/pubs-resources NHIS-2017.html Accessed 28 November 2021.
  24. Burger EA, Kim JJ, Sy S, Castle PE. Age of acquiring casual Human Papillomavirus (HPV) infections: leveraging simulation models to explore the natural history of HPV-induced cervical cancer. Clin Infect Dis. 2017;65(6):893-899.
  25. The American College of Obstetricians and Gynecologists. The HPV Vaccine is a Lifesaver. Available at: https://www.acog.org/womens-health/infographics/the-hpv-vaccine-is-a-lifesaver. Accessed 28 November 2021.
  26. Smith E, Swamavel S, Ritchie J, Wang D, Haugen T, Turek L. Prevalance of Human Papillomavirus in the Oral Cavity/Oroppharynx in a Large Population of Children and Adolescents. Pediatrics Infectious Disease Journal. 2007;26(9):836-840.
  27. National Cancer Institute (NIH). HPV and Cancer. 2021. Available from: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer. Accessed 18 January 2022.
  28. American Sexual Health Association. HPV Myths&Facts. 2021. Available at: https://www.ashasexualhealth.org/hpv-myths-facts/. Accessed 5 January 2023.
  29. Society of Behavioral Medicine. Myths about the HPV Vaccine: HPV Vaccine Facts and Science Behind Them. 2021. Available from: https://www.sbm.org/healthy-living/7-hpv-vaccine-myths. Accessed 12 December 2021.
  30. Bednarczyk R. Addressing HPV vaccine myths: practical information for healthcare providers. Human Vaccines / Immunotherapeutics. 2019;15(7-8):1628-1638.
  31. Centers for Disease Control and Prevention (CDC). What Can I Do To Reduce My Risk of Cervical Cancer? 12 Jan 2021. Available at: https://www.cdc.gov/cancer/cervical/basic_info/prevention.htm. Accessed 28 November 2021.
  32. Centers for Disease Control and Prevention (CDC). What Should I Know About Screening? Available at: https://www.cdc.gov/cancer/cervical/basic_info/screening.htm. Last access: 3-Oct-22.
  33. National Cancer Institute. Human Papillomavirus (HPV) Vaccines. Available at https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet. Accessed 5 January 2023.
  34. National Center for Biotechnology Information (NCBI). Human Papillomavirus Vaccines. 2021. Available from: https://ncbi.nlm.nih.gov/books/NBK501705/ Accessed 7 January 2022.
  35. Centers for Disease Control and Prevention (CDC). HPV Vaccine Administration. 2021. Available from: https://www.cdc.gov/vaccines/vpd/hpv/hcp/administration.html Accessed 5 January 2023.
  36. Centers for Disease Control and Prevention (CDC). HPV Vaccine Schedule and Dosing. 2021. Available from: https://www.cdc.gov/hpv/hcp/schedules-recommendations.html Accessed 7 January 2022.
  37. Centers for Disease Control and Prevention (CDC). Human Papillomavirus (HPV) Vaccination: What Everyone Should Know. Available at https://www.cdc.gov/vaccines/vpd/hpv/public/index.html Accessed 5 January 2023.
  38. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. New England Journal of Medicine 2002;347(21):1645-1651.
  39. Gillison. ML, Chatuverdi AK, Lowy DR. HPV propphylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008; 113(10 Suppl):3036-3046.
  40. Thompson-Harvey A, Yetukuti M, Hansen AR, et al. Rising incidence of late-stage head and neck cancer in the United States. Cancer 2020;126(5):1090-1101.

REFERENCES

Copyright © 2023 Merck & Co., Inc., Rahway, NJ, USA and its affiliates.
All rights reserved. AE-NON-00279 Expiry: September 2024. In case you need any update or you have an inquiry or need to report an adverse reaction, you can contact Tel: +9714 4269100 Fax: +9714 4269204 Email: DPOC.GULF@MERCK.COM

This website is intended for UAE residents.

MOH approval code: 145409-0225 | Expiry Date: 07/11/2024